ulrich medical USA® Announces Strong Financial Performance of U.S. Spine Business
Delivers Record-Breaking 5-Year Results ~ 18% Revenue CAGR and 27% EBITDA CAGR
ST. LOUIS, MO (February 17, 2016) – ulrich medical USA Inc., a medical device company focused on developing and commercializing musculoskeletal implant technologies in the United States, today reported a fifth consecutive year of profitable, double-digit growth for the U.S. spine business and a 20% top line growth for the year ending December 31, 2015. Equally as strong, the company announced a 5-year revenue compound annual growth rate (CAGR) of 18% and a 27% EBITDA CAGR over the same period.
